Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with pancreatic ductal adenocarcinoma (a specific type of pancreatic cancer) confirmed by tissue or cell testing, or who are strongly suspected of having this condition before surgery aimed at curing it
- People who have not yet received any treatment for this cancer
- People aged 18 years or older
- People who are able and willing to provide written consent to participate
Who may not be able to join:
- People who have papillary cancer (a different type of cancer)
- People who have neuroendocrine pancreatic tumors (a different type of pancreatic tumor)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thomas Seufferlein, MD, Ulm University Hospital
Phone: +49 731 50044501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
General assessment of applied therapy modalities in pancreatic cancer; Quality of life in pancreatic cancer patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.